At the same time, the proportion of P1-2, while still less prevalent, showed an increasing trend, rising from 20.1% (95% CI 14.2–26.5) to 32.2% (95% CI 13.1–54.9).
← all excerpts
Global molecular epidemiology of <i>Mycoplasma pneumoniae</i> and its association with macrolide resistance and disease severity: a systematic review and meta-analysis.
2
—
—
The sentences
In recent years, the proportion of P1-1, although remaining relatively high, showed a decreasing trend, declining from 80.0% (95% CI 73.5–85.8) between 2010 and 2014 to 67.8% (95% CI 45.1–86.9) between 2020 and 2024.